Screener
Revolution Medicines, Inc. RVMD Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-208969
FAQ
- What is Revolution Medicines, Inc.'s accounts payable?
- Revolution Medicines, Inc. (RVMD) reported accounts payable of $80.54M in Q1 2026.
- How has Revolution Medicines, Inc.'s accounts payable changed year-over-year?
- Revolution Medicines, Inc.'s accounts payable increased by 69.5% year-over-year, from $47.51M to $80.54M.
- What is the long-term trend for Revolution Medicines, Inc.'s accounts payable?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s accounts payable has grown at a 52.9% compound annual growth rate (CAGR), from $44.63M to $243.73M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Revolution Medicines, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude